CHENGDU, China, 25 de agosto de 2026 /PRNewswire/ -- El 19 de agosto de 2026, Keymed Biosciences (HKEX: 02162) ha dado a conocer sus resultados provisionales para el semestre finalizado el 30 de junio de 2026, con unos ingresos totales de 617 millones de RMB. Su producto principal,...
Hence then, the article about keymed biosciences anuncia los resultados del primer semestre de 2026 y novedades empresariales was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Keymed Biosciences anuncia los resultados del primer semestre de 2026 y novedades empresariales )
Also on site :
- Mary Janes Are ‘Timeless’ Fall Footwear, and This ‘Chic’ $30 Pair Is ‘Comfortable’ All Day With No Break-in Required
- I Toured JetBlue’s New BlueHouse Lounge at Boston Logan—Here’s a Look Inside the Cozy, Locally Inspired Space
- Professional Chef Says These 3 ‘Old-Fashioned’ Meals from the 1940s Are the Definition of ‘Comfort Food’